Introduction
The prevalence rate of hypertension is B26% of the adult population. 1 Studies have reported that 60-75% of treated hypertensive patients did not achieve the recommended target of blood pressure levels, 2, 3 and this is attributed to non-adherence to antihypertensive pharmacotherapy. 4 Despite the well-recognized evidence that proper antihypertensive drug therapy could reduce cardiovascular diseases and mortality, [5] [6] [7] the problem of nonadherence could lead to an unnecessary adjustment of drug regimens. It has been estimated that the total costs of hypertension were 76.5 million pound sterling per annum, of which 26.9 million pound sterling was attributed to patients who switched or discontinued therapy. 8 Published literatures have identified the independent predictors of antihypertensive drug non-persistence [9] [10] [11] [12] [13] among Caucasian patients. However it is well recognized that pharmacological actions of antihypertensive drugs are different in patients of different ethnicity, 14 and it is unknown whether these findings could be easily generalizable to ethnic Chinese patients, who constitute one-fifth of the world's population living in different parts of the globe.
We recently conducted large-scale studies on discontinuation profiles of antihypertensive drugs in a public setting among Chinese patients with only uncomplicated hypertension 15, 16 and among those with concomitant comorbidities. 17 Users of b-blockers were found to have the highest discontinuation rates. However, although drug discontinuation (without substitution of another drug class) is largely attributed to patients' follow-up default or medication non-adherence, drug switching is an equally important measure in pharmacoepidemiology studies as its occurrence is more likely linked to antihypertensive side effects and inadequate blood pressure control. 18 Thus far, antihypertensive switching profiles have not been adequately explored in ethnic Chinese patients.
This study evaluated factors associated with antihypertensive drug switching among ethnic Chinese patients. We tested the hypothesis that users of thiazide diuretics had the highest switching rates when compared with users of other major antihypertensive drug classes, as reported in a study by Mazzaglia et al. 10 
Materials and methods
Source and collection of data A detailed description of the database was described elsewhere. 17, 18 This study used the CDARS (Clinical Data Analysis Reporting System) of the Hospital Authority of Hong Kong, which consists of 7 million patient records, 1 million annual admissions and 13 million ambulatory visits. One of its objectives is to aid in research. 19 The database contained patients' clinical and demographic information, clinical diagnoses in terms of ICPC (International Classification of Primary Care) codes, types of clinical services (GOPC (general outpatient) vs FMSC (family medicine specialist clinic) vs staff clinics), as well as drug prescription details. We assigned a number of comorbidities to each patient according to the number of concomitant cardiovascular disorders other than K86 (uncomplicated hypertension) (for example, lipid disorders, diabetes mellitus, cerebrovascular diseases), diseases which were compelling indications or contraindications of a particular class of antihypertensive drugs (for example, ischaemic heart diseases, asthma, gout, chronic obstructive pulmonary diseases), or medical conditions that could potentially confound the prescription choice of antihypertensive agents (for example, heart failure, benign prostatic hypertrophy). A complete list of these diseases as identified by their respective ICPC codes is shown in Supplementary Table 1 . We previously evaluated this database and reported a high level of data completeness on demographic information (100%) and prescription details (99.98%). 20 These computerized records are the only conduits of information entry reported by physicians at each patient visit in all primary care clinics run by the HA. There exist clinical guidelines for every physician regarding the need to enter diagnosis of the consultation in the form of ICPC codes. Data sources in this study include patient information obtained from the NTE (New Territory East) cluster of Hong Kong (one out of its seven clusters), which provides primary health-care services to B1.3 million residents, representing 17.2% of Hong Kong's population. 21 The NTE is further divided into three separate geographical regions, namely Shatin, Taipo and North District, from the most urbanized to the least. Their median monthly household incomes in 2006 were US$2510, US$2338 and US$2078, respectively, compared with the Hong Kong wide figure of US$2240. 21 These three regions had similar median ages (38-39 years), comparable with the median age of 39 years for Hong Kong. This study was approved by the Survey and Research Behavioural Ethics Committee, Chinese University of Hong Kong.
Definition of the cohort
We included all adult patients aged X18 years who had attended a primary care clinic and paid at least two consecutive visits for antihypertensive medication refill in the NTE region during the study period from January 2004 to June 2007, irrespective of the number of their ICPC coding. We used the prescription of antihypertensive drugs as patient retrieval criteria. The diagnosis of hypertension, which usually requires at least three separate readings of blood pressure 4140/90 mm Hg, was established by the attending physicians.
Exposure to drugs and assessment of switching The major outcome variable is the cumulative incidences of drug switching within 180 days of their prescription. Drug switching is defined as the absence of a refill prescription in all subsequent clinic visits with issuance of another antihypertensive drug of a different antihypertensive drug class, within the time frame of 180 days since the first prescription date. Demographic variables were reported according to the drug class prescribed (thiazide diuretics, b-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, combination therapy and 'others'). Combination therapy is defined as a single pill consisting of more than one active antihypertensive ingredient. 'Other' drug classes include a-blockers, potassium-sparing diuretics, loop diuretics, vasodilators and polytherapies (defined as at least two separate drugs consisting of different antihypertensive ingredients).
Covariables and statistical analysis
Chi-squared tests of heterogeneity were used to analyse categorical variables. The potential independent variables were hypothesis-driven and included patients' age, gender, payment status (fee waivers vs fee payers), service types (GOPC vs FMSC vs staff clinics), district of residence (Shatin vs Taipo vs North District vs others), visit type (new vs subsequent), calendar years of drug prescription and antihypertensive drug classes. One binary logistic regression analysis was conducted among all patients, with cumulative incidences of drug switching within 180 days as the outcome variable. We further stratified patients into different age (o50, 50-69, X70 years) and gender (male and female) groups, and conducted separate regression analyses to detect any differences in factors associated with antihypertensive discontinuation among these patient subgroups. All predictor variables were entered unconditionally into the regression equations. We used the Statistical Package for Social Sciences version 15.0 (SPSS Incorporation, Chicago, IL, USA). All P-values o0.05 were considered statistically significant.
Results

Patient characteristics
After excluding 1295 patients who died before the first day of the next prescription period, there were a total of 93 286 eligible patients with an average age of 62.7 years and a female proportion of 56.8% (Table 1) . The majority of patients were prescribed combination therapies (31.4%), followed by calcium channel blockers (23.2%) and b-blockers (20.6%). Most of them were fee payers (73.4%), attendees of GOPC (90.6%) and lived in more urbanized districts (70.9%). There were 56.4% new visitors, and most had uncomplicated hypertension as their only medical condition (72.8%) ( Table 1) .
Antihypertensive drug switchers vs non-switchers A total of 5281 patients (5.7%) had their drugs switched 180 days within the first date of prescription (Table 2) . When compared with non-switchers, switchers were younger, comprised more female patients, attended the FMSC, lived in more urbanized regions and included more new visitors. In addition, more switchers had uncomplicated hypertension without concomitant comorbidities and were prescribed either thiazide diuretics or combination therapies. Significantly less switchers were prescribed b-blockers, calcium channel blockers and angiotensin-converting enzyme inhibitors ( Table 2) . For sensitivity analyses, when we used each antihypertensive drug class as the reference group and reconstructed separate regression equations, similar findings were reported (results not shown).
Factors associated with drug switching in different age and gender groups When patients were stratified into male and female groups, gender was found to be a significant influencer of factors associated with drug switching (Table 4 ). In particular, only young female patients (aOR of X70 years 0.83, P ¼ 0.001), female residents of Taipo district (aOR 0.80, Po0.001) and female patients having only one concomitant comorbidity (aOR 0.85, P ¼ 0.002) were positively associated with antihypertensive drug switching. In addition, stratification of patients into different age groups also altered these associated factors (Table 5 ). It was reported that only female patients aged o50 years (aOR 0.75, Po0.001) and those aged 50-69 years (aOR 0.85, Po0.001) were more likely to have their drugs switched when compared with male patients. Besides, attendees of the FMSC aged 50-69 years (aOR 1.27, P ¼ 0.002) and X70 years (aOR 1.41, Po0.001) were more likely to have their drugs switched, whereas residents of Taipo aged X70 years (aOR 0.84, P ¼ 0.007) were less likely to switch drugs.
Discussion
Previous studies in Italy reported a switching rate of 52.4% over a period of 30.8 months on the basis of patient questionnaires, 18 and a rate of 15.4% over 1 year as per the Health Search Database. 10 The 180-day switching incidence found in this study was hence comparatively low. Most studies have shown that older patients adhere better to medication regimens than do younger patients, but the findings were inconsistent. [22] [23] [24] [25] Moreover, there exist conflicting data on whether male or female patients adhere better to antihypertensive treatments. 22, 26 Crude rates of drug switching in different age (5.4-6.0%) and gender groups (5.3-6.0%) showed small variations in this study, and we interpreted age and gender as statistically significant, yet clinically less significant, factors associated with antihypertensive switching.
Our study participants were relatively healthy as reflected by the low number of comorbidities, which Combination therapies refer to the prescription of a single pill consisting of more than two active antihypertensive ingredients.
Switching of antihypertensive drugs in Chinese
MCS Wong et al might explain why the majority of them were seen by general practitioners in GOPC. We included patients who were too homogeneously healthy to demonstrate large variability with regard to the incidence of comorbidities. It is unknown why the absence of concomitant comorbidities was associated with drug switching. However, this finding was consistent with many studies, which reported the same, in which multiple chronic conditions have been recognized as an adherence facilitator. 27 One potential explanation could be the higher threshold for physicians to switch an antihypertensive drug when it is a compelling indicator of certain comorbidities. A notable example is the use of b-blockers in coronary heart disease, wherein physicians could hesitate to switch the medication even if the patient is relatively intolerant to drug-related side effects. In addition, follow-up visitors were less likely to have their drugs switched when compared with new patients, and previous studies have reported that antihypertensive persistence may be as low as 45% for newly diagnosed patients. 27, 28 This could be attributed to the relatively inadequate knowledge and negative beliefs about the treatment of hypertension among patients newly diagnosed with hypertension, as they were likely to be antihypertensive drug naive. These have been recognized as patient barriers to antihypertensive adherence. 27 With regard to service settings, patients who attended the FMSC were more likely to have their Combination therapies refer to the prescription of a single pill consisting of more than two active antihypertensive ingredients.
Switching of antihypertensive drugs in Chinese MCS Wong et al drugs switched. This is contrast to our expectations as stronger patient-provider relationship and patient involvement in their treatment decisions were considered to be adherence facilitators. 27 Therefore, one explanation for this could be the presence of more family medicine specialists and longer contact hours for each patient in FMSC, and thus better opportunities to review the side effects of medications, and probably a lower threshold for physicians to switch medications when patients presented with drug intolerability. The finding that users of thiazide were the most likely to switch as compared with all other major antihypertensive drug class was compatible with findings from many literatures. These include studies by Burke et al. 9 and Mazzaglia et al. 10 who found the lowest median time to drug discontinuation. Locally in Hong Kong, Chinese patients have also been found to tolerate b-blockers better, and patients on a diuretic complained of side effects more frequently than did users of other drug classes, 29 mainly due to dizziness and polyuria.
Study strengths and weaknesses
The definition of switching in this study is similar to that of previous studies, 9, 10 except that a longer time frame of 180 days was used instead of 90 days, taking into account the variable practice of prescribing antihypertensive drugs for a period of 14-168 days (median 56 days) in our database. We included a large number of patients in this study over a period of 3.5 years. In conjunction with the high completeness of the database and the validity of the drug information attributed to good dispensing practices, it allows for robustness of data analyses. Similar demographics of these three regions compared with Hong Kong makes generalizability more convincing.
Some limitations of this study should be addressed. First, we included patients attending the public sector from only one district of Hong Kong. However, similar patterns of prescribing to those found in this study have been reported in previous smaller studies in other regions of Hong Kong, and therefore it is likely that our findings are generalizable in terms of primary care within the public Combination therapies refer to the prescription of a single pill consisting of more than two active antihypertensive ingredients.
Switching of antihypertensive drugs in Chinese MCS Wong et al health-care system in Hong Kong. Moreover, uncomplicated hypertension is the second most common condition seen in primary care clinics in the public health-care sector in Hong Kong, 30 and available data suggest that a substantial proportion of the population attends public health services rather than the private sector for management of hypertension. 31 Thus, our findings may well be of significance at a population level in terms of health services utilization.
Second, the majority of our study participants have no concomitant comorbidities, and the findings are therefore only applicable to a relatively healthy population. In addition, we captured the patterns of antihypertensive utilization over a relatively short study period. Another limitation inherent in all database study was the uncertainty of whether patients were indeed taking the medications as prescribed, and the reasons for switching could not be evaluated. The goodness of fit of the regression equations were far from complete, suggesting that other variables including physician-, practice-and patient-related factors in real clinical practice could contribute to medication switching.
Conclusions
The most important implication that follows this study is straightforward-physicians should practice extra caution when prescribing antihypertensive medications to young, female or drug-naive patients as they might have a higher risk of drug switching, arguably due to medication side effects. A more thorough explanation of the side effect profiles of antihypertensive drugs could potentially prompt the patient to observe for adverse effects in the first few weeks after drug prescriptions. This is particularly important for patients who presented with associated factors identified in this study. Future studies should identify the class-specific reasons for antihypertensive drug switching among this Chinese population to optimize prescription practices.
